Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation

Journal of Hepatology

Volumn 58, Issue 3, 2013, Pages 634-635

  Samson, Susan Leanne ^a   Bajaj, Mandeep ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL PEPTIDASE IV; EXENDIN 4; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INCRETIN; TRIACYLGLYCEROL;

DRUG BLOOD LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; ENZYME SYNTHESIS; FATTY ACID SYNTHESIS; FATTY LIVER; GLUCONEOGENESIS; LETTER; LIVER CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; GLUCAGON-LIKE PEPTIDE 1; LIPOGENESIS; LIVER; MALE;

EID: 84874105335     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.10.032     Document Type: Letter

References (10)

1. S. Ben-Shlomo, I. Zvibel, M. Shnell, A. Shlomai, E. Chepurko, and Z. Halpern Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase J Hepatol 54 2011 1214 1223
2. X. Ding, N.K. Saxena, S. Lin, N.A. Gupta, and F.A. Anania Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice Hepatology 43 2006 173 181
3. J. Shirakawa, H. Fujii, K. Ohnuma, K. Sato, Y. Ito, and M. Kaji Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice Diabetes 60 2011 1246 1257
4. S.L. Samson, E.V. Gonzalez, V. Yechoor, M. Bajaj, K. Oka, and L. Chan Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model Mol Ther 16 2008 1805 1812
5. S.L. Samson, P. Sathyanarayana, M. Jogi, E.V. Gonzalez, A. Gutierrez, and R. Krishnamurthy Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial Diabetologia 54 2011 3093 3100
6. G. Svegliati-Baroni, S. Saccomanno, C. Rychlicki, L. Agostinelli, M.S. De, and C. Candelaresi Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis Liver Int 31 2011 1285 1297
7. J. Lee, S.W. Hong, S.W. Chae, D.H. Kim, J.H. Choi, and J.C. Bae Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice PLoS One 7 2012 e31394
8. B. Viollet, B. Guigas, J. Leclerc, S. Hebrard, L. Lantier, and R. Mounier AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives Acta Physiol (Oxf) 196 2009 81 98
9. M. Foretz, and B. Viollet Regulation of hepatic metabolism by AMPK J Hepatol 54 2011 827 829
10. E. Tomas, and J.F. Habener Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis Trends Endocrinol Metab 21 2010 59 67